Drug & supplement interaction

1,3-dmaa + Liraglutide Recombinant

Liraglutide Recombinant brand name: Saxenda.

No Known Interaction
Medically reviewed by · Updated July 2026 · Pair last verified Sep 13, 2026
The bottom line No known interaction

We found no known interaction between 1,3-dmaa and Liraglutide Recombinant in our sources. Absence of a documented interaction is not the same as proven safety, and does not guarantee one does not exist. Do not start, stop, or change a medication or supplement based on this page; confirm with your pharmacist or doctor first. Additionally, although there is no interaction, the two are separately associated with some of the same side effects, which would make a new symptom harder to attribute to one or the other.

Know someone taking this? Share
Facebook Post Reddit Email
On this page
Interaction report

1,3-dmaa and Liraglutide Recombinant

We checked these two against our interaction database. Here is what we found.

No Known Interaction Found

We did not find a documented interaction between Liraglutide Recombinant and 1,3-dmaa in our sources. This does not guarantee that the combination is completely free of risk — there is often limited research on supplements and herbal products, especially around drug interactions.

If you decide to take both, the practical routine is simple: add one new thing at a time and note the date you started it. If the combination is going to disagree with you, it usually shows in the first days to a couple of weeks — and a start date turns “I’ve been feeling off” into something a pharmacist can actually work with. Do not stop a prescribed medicine on your own.

Always talk with your pharmacist or doctor before making changes to your medications or supplements, particularly if you take several medications or have an ongoing health condition.

1,3-dmaa safety at a glance

1,3-dmaa overall Avoid DMAA is banned in supplements in many countries and tied to serious cardiovascular harm.
Pregnancy Avoid It is an unsafe stimulant with no safety data; do not use during pregnancy.
Breastfeeding Avoid No safety data and known stimulant risks; do not use while breastfeeding.

Safety guidance is general; always confirm with your pharmacist or doctor for your situation.

Still wondering about combining Liraglutide Recombinant and 1,3-dmaa? Ask Dr. Brian Staiger, PharmD, BCPS directly ›
How we checked

Why No Interaction Is Listed for Liraglutide Recombinant

Interactions in our licensed database are recorded against drug classes, not just single drug names. Liraglutide Recombinant is filed under a single classification — antidiabetes drugs. 1,3-dmaa has documented interactions with 2 drug classes — the most serious being cytochrome p450 2d6 (cyp2d6) substrates (moderate) and stimulant drugs (moderate) — and none of Liraglutide Recombinant’s classifications are among them.

Classification data comes from our licensed Natural Medicines dataset. A medication can belong to classes beyond those recorded there, so this describes how the check was run — it is not a safety guarantee.

Keep it in perspective

1,3-dmaa Does Interact With Other Medications

1,3-dmaa has 321 moderate known drug interactions in our database — Liraglutide Recombinant isn’t one of them. If you take anything else, check it against the full list below.

Moderate 321 No known interaction 2,509 (incl. Liraglutide Recombinant)
Taking anything else?

Check Another of Your Medications Against 1,3-dmaa

Covers the 2,830 medications we’ve checked against 1,3-dmaa. Pick one to open its full report.

What to actually watch for

No Interaction Found — But Data Suggests 1,3-dmaa and Liraglutide Recombinant May Share Several of the Same Side Effects

This is not an interaction. Neither one changes how your body handles the other, and nothing here says they react together. What our sources do show is that each has separately been linked to the effects below — so taking both can make those effects more likely to turn up, and harder to pin on one or the other if they do. 2 of them are worth acting on rather than waiting out — marked below.

  • Low mood Worth acting on Additional detail

    1,3-dmaa

    “Orally, taking 1,3-DMAA-containing combination products has been reported to cause feelings of anxiety, suicidal behavior, agitation or irritability, paranoia, depression, panic, and aggression or combativeness.”

    1,3-dmaa · Natural Medicines adverse-effect record, reported in anxiety.

    5 sources cited
    1. 17907. McCarthy C, Canale RE, Alleman RJ, et al. Biochemical and anthropometric effects of a weight loss dietary supplement in health men and women. Nutr Metab Insights 2012;5:13-22.
    2. 94365. Brown JA, Buckley NA. Toxicity from bodybuilding supplements and recreational use of products containing 1,3-dimethylamylamine. Med J Aust. 2013 May 6;198(8):414-5. PubMed
    3. 94371. Forrester M. Exposures to 1,3-dimethylamylamine-containing products reported to Texas poison centers. Hum Exp Toxicol. 2013 Jan;32(1):18-23. PubMed
    4. 94377. Van Hout MC, Hearne E. "Plant or poison": A netnographic study of recreational use of 1,3-dimethylamylamine (DMAA). Int J Drug Policy. 2015 Dec;26(12):1279-81. PubMed
    5. 17660. Adverse Event Report. Jack3d. Natural MedWatch, May 28, 2011.

    Liraglutide Recombinant

    Listed in the ADVERSE REACTIONS section of the FDA label for Liraglutide Recombinant. Read the label on DailyMed ›

  • Raised blood pressure Worth acting on Additional detail

    1,3-dmaa

    “Orally, taking 1,3-DMAA combination products (OxyELITE Pro, AmphetaLean, or Jack3d, USPlabs) has been reported to cause cardiac arrest, atrial fibrillation, chest pressure, angina, tachycardia, palpitations, hypertension, hypotension, myocardial infarction, and acute coronary syndrome. Increased heart rate and blood pressure have also been reported.”

    1,3-dmaa · Natural Medicines adverse-effect record, reported in angina.

    6 sources cited
    1. 17660. Adverse Event Report. Jack3d. Natural MedWatch, May 28, 2011.
    2. 91680. Smith TB, Staub BA, Natarajan GM, et al. Acute myocardial infarction associated with dietary supplements containing 1,3-dimethylamylamine and Citrus aurantium. Tex Heart Inst J 2014;41(1):70-2. PubMed
    3. 94361. Archer JR, Dargan PI, Lostia AM, van der Walt J, Henderson K, Drake N, Sharma S, Wood DM, Walker CJ, Kicman AT. Running an unknown risk: a marathon death associated with the use of 1,3-dimethylamylamine (DMAA). Drug Test Anal. 2015 May;7(5):433-8. PubMed
    4. 94362. Armstrong M. Atrial Fibrillation with Rapid Ventricular Response following use of Dietary Supplement Containing 1,3 Dimethylamylamine and Caffeine. J Spec Oper Med. 2012 Winter;12(4):1-4. PubMed
    5. 94365. Brown JA, Buckley NA. Toxicity from bodybuilding supplements and recreational use of products containing 1,3-dimethylamylamine. Med J Aust. 2013 May 6;198(8):414-5. PubMed
    6. 94369. Eliason MJ, Eichner A, Cancio A, Bestervelt L, Adams BD, Deuster PA. Case reports: Death of active duty soldiers following ingestion of dietary supplements containing 1,3-dimethylamylamine (DMAA). Mil Med. 2012 Dec;177(12):1455-9. PubMed

    “Due to the stimulant effects of 1,3-DMAA, there is concern that it might increase the risk of adverse cardiovascular events similar to synephrine from bitter orange or ephedrine from ephedra. Cardiovascular outcomes have rarely been assessed in patients taking 1,3-DMAA alone. Most adverse effects are linked to 1,3-DMAA-containing combination products.”

    1,3-dmaa · Natural Medicines adverse-effect record, reported in angina.

    6 sources cited
    1. 17660. Adverse Event Report. Jack3d. Natural MedWatch, May 28, 2011.
    2. 91680. Smith TB, Staub BA, Natarajan GM, et al. Acute myocardial infarction associated with dietary supplements containing 1,3-dimethylamylamine and Citrus aurantium. Tex Heart Inst J 2014;41(1):70-2. PubMed
    3. 94365. Brown JA, Buckley NA. Toxicity from bodybuilding supplements and recreational use of products containing 1,3-dimethylamylamine. Med J Aust. 2013 May 6;198(8):414-5. PubMed
    4. 94371. Forrester M. Exposures to 1,3-dimethylamylamine-containing products reported to Texas poison centers. Hum Exp Toxicol. 2013 Jan;32(1):18-23. PubMed
    5. 94362. Armstrong M. Atrial Fibrillation with Rapid Ventricular Response following use of Dietary Supplement Containing 1,3 Dimethylamylamine and Caffeine. J Spec Oper Med. 2012 Winter;12(4):1-4. PubMed
    6. 94377. Van Hout MC, Hearne E. "Plant or poison": A netnographic study of recreational use of 1,3-dimethylamylamine (DMAA). Int J Drug Policy. 2015 Dec;26(12):1279-81. PubMed

    Liraglutide Recombinant

    Listed in the ADVERSE REACTIONS section of the FDA label for Liraglutide Recombinant. Read the label on DailyMed ›

  • Anxiety or restlessness Additional detail

    1,3-dmaa

    Recorded for 1,3-dmaa in the same Natural Medicines adverse-effect record shown under Raised blood pressure above.

    Liraglutide Recombinant

    Listed in the ADVERSE REACTIONS section of the FDA label for Liraglutide Recombinant. Read the label on DailyMed ›

  • Trouble sleeping / Tiredness / Headache Additional detail

    1,3-dmaa

    “Orally, taking specific 1,3-DMAA-containing combination products (OxyELITE Pro or Jack3d, USPlabs) has been reported to cause feelings of jitters, sleeplessness, shakiness, chills, sweating, fatigue, tingling, and lack of focus in clinical trials.”

    1,3-dmaa · Natural Medicines adverse-effect record, reported in cluster headache.

    6 sources cited
    1. 17907. McCarthy C, Canale RE, Alleman RJ, et al. Biochemical and anthropometric effects of a weight loss dietary supplement in health men and women. Nutr Metab Insights 2012;5:13-22.
    2. 17660. Adverse Event Report. Jack3d. Natural MedWatch, May 28, 2011.
    3. 17908. Farney TM, McCarthy C, Canale RE, et al. Hemodynamic and hematologic profile of health adults ingesting dietary supplements containing 1,3-dimethylamylamine and caffeine. Nutr Metab Insights 2012;5:1-12.
    4. 94365. Brown JA, Buckley NA. Toxicity from bodybuilding supplements and recreational use of products containing 1,3-dimethylamylamine. Med J Aust. 2013 May 6;198(8):414-5. PubMed
    5. 94368. Dunn M. Have prohibition policies made the wrong decision? A critical review of studies investigating the effects of DMAA. Int J Drug Policy. 2017 Feb;40:26-34. PubMed
    6. 94371. Forrester M. Exposures to 1,3-dimethylamylamine-containing products reported to Texas poison centers. Hum Exp Toxicol. 2013 Jan;32(1):18-23. PubMed

    Liraglutide Recombinant

    Listed in the ADVERSE REACTIONS section of the FDA label for Liraglutide Recombinant. Read the label on DailyMed ›

  • Stomach pain / Diarrhea / Vomiting Additional detail

    1,3-dmaa

    “Orally, taking 1,3-DMAA-containing combination products has been reported to cause nausea, vomiting, diarrhea, vomiting blood, and abdominal pain.”

    1,3-dmaa · Natural Medicines adverse-effect record, reported in diarrhea.

    6 sources cited
    1. 17907. McCarthy C, Canale RE, Alleman RJ, et al. Biochemical and anthropometric effects of a weight loss dietary supplement in health men and women. Nutr Metab Insights 2012;5:13-22.
    2. 17908. Farney TM, McCarthy C, Canale RE, et al. Hemodynamic and hematologic profile of health adults ingesting dietary supplements containing 1,3-dimethylamylamine and caffeine. Nutr Metab Insights 2012;5:1-12.
    3. 94365. Brown JA, Buckley NA. Toxicity from bodybuilding supplements and recreational use of products containing 1,3-dimethylamylamine. Med J Aust. 2013 May 6;198(8):414-5. PubMed
    4. 94371. Forrester M. Exposures to 1,3-dimethylamylamine-containing products reported to Texas poison centers. Hum Exp Toxicol. 2013 Jan;32(1):18-23. PubMed
    5. 94377. Van Hout MC, Hearne E. "Plant or poison": A netnographic study of recreational use of 1,3-dimethylamylamine (DMAA). Int J Drug Policy. 2015 Dec;26(12):1279-81. PubMed
    6. 17663. Gee P, Jackson S, Easton J. Another bitter pill: a case of toxicity from DMAA party pills. N Z Med J 2010;123:124-7.

    Liraglutide Recombinant

    Listed in the ADVERSE REACTIONS section of the FDA label for Liraglutide Recombinant. Read the label on DailyMed ›

  • Dizziness Additional detail

    1,3-dmaa

    Recorded for 1,3-dmaa in the same Natural Medicines adverse-effect record shown under Trouble sleeping / Tiredness / Headache above.

    Liraglutide Recombinant

    Listed in the ADVERSE REACTIONS section of the FDA label for Liraglutide Recombinant. Read the label on DailyMed ›

Showing the 10 most notable of 11 shared effects — ranked by how unusual each one is, not just whether both lists mention it.

Reported for 1,3-dmaa but not commonly for Liraglutide Recombinant: a heart attack, a fast or pounding heartbeat, an irregular heartbeat and blurred vision.

Effects for Liraglutide Recombinant come from the ADVERSE REACTIONS section of its FDA label; effects for 1,3-dmaa come from the Natural Medicines adverse-effect record, quoted above. Wording is matched across sources by our own clinical vocabulary, so treat this as a prompt to pay attention, not a diagnosis.

Overlapping uses

What Liraglutide Recombinant Is Prescribed For, and What 1,3-dmaa Has Been Studied For

These two come up together because they touch the same health topic — not because they do the same job. Liraglutide Recombinant is a prescription medicine with approved uses on its FDA label. 1,3-dmaa is a supplement: what follows is what researchers have looked at it for, and how strong that evidence is.

Liraglutide Recombinant is prescribed for: Saxenda is used alongside a reduced-calorie diet and increased physical activity for chronic weight management. It is approved for adults with a BMI of 30 or higher, or a BMI of 27 or higher if they also have at least one weight-related condition such as high blood pressure, type 2 diabetes, or dyslipidemia (abnormal cholesterol or fat levels). It is also approved for adolescents aged 12 and older who weigh more than 60 kg and meet certain BMI thresholds for obesity. Saxenda should not be used together with other liraglutide-containing products or any other GLP-1 receptor agonist.

Read the rest of what Liraglutide Recombinant is prescribed for

Its safety and effectiveness in combination with other prescription or over-the-counter weight-loss products have not been established.

1,3-dmaa has been studied for:

  • Obesity studied, not established 1,3-dmaa has been studied for this. Natural Medicines rates the evidence: Insufficient Reliable Evidence To Rate Read what the research shows

    1,3-dmaa for obesity

    Preliminary clinical research suggests a specific combination product, containing 1,3-DMAA, caffeine, and other ingredients (OxyELITE Pro, USPLabs), could potentially affect weight or body fat loss. Taking a single 2-capsule dose seems to significantly increase calorie expenditure and markers of lipolysis within 1-2 hours compared to placebo in a small sample of healthy, exercise trained men and women.

    2 sources cited
    1. 17906. McCarthy C, Farney TM, Canale RE, et al. A finished dietary supplement stimulates lipolysis and metabolic rate in young men and women. Nutr Metab Insights 2012;5:23-31. PubMed
    2. 17907. McCarthy C, Canale RE, Alleman RJ, et al. Biochemical and anthropometric effects of a weight loss dietary supplement in health men and women. Nutr Metab Insights 2012;5:13-22.

Effectiveness ratings and the research summaries above are the verbatim record from the Natural Medicines database, which grades evidence from “Effective” down to “Insufficient Reliable Evidence To Rate”. A rating below the top of that scale means researchers have looked at it — not that it works, and never that it can stand in for a prescribed medicine. Do not stop or replace Liraglutide Recombinant on your own; if you are taking 1,3-dmaa for the same health topic, tell your prescriber, especially if the medicine is being adjusted to a target.

Everything else you take

See Every Supplement That Interacts With Liraglutide Recombinant

This page covers 1,3-dmaa only. If you take other supplements — a multivitamin, a sleep aid, something for joints — the Liraglutide Recombinant page lists 239 supplements it has a documented interaction with, worst first, each one explained.

The most serious there right now: Siberian Cocklebur (major), Acai (moderate), African Wild Potato (moderate), Agaricus Mushroom (moderate) and Agmatine (moderate).

By severity: 1 major · 208 moderate · 30 minor.

From our pharmacist’s overview on the Liraglutide Recombinant page

“If you take liraglutide (Saxenda), handle this page with real care, because all 239 ingredients on it act on the same thing the drug does, your blood sugar. The one major entry, Siberian cocklebur, has caused severe hypoglycemia, dangerously low blood sugar, in people and should never be combined with a glucose-lowering medicine.”

Reviewed by 2 · Jul 18, 2026

Open the Liraglutide Recombinant interaction page

One more smart check

Taking 1,3-dmaa as Part of a Dietary Supplement Product? Check It for Interactions

We hold 94 real supplement products containing 1,3-dmaa, each one broken down to its full ingredient list — and combination products often carry several ingredients besides 1,3-dmaa. Even though 1,3-dmaa itself has no known interaction with Liraglutide Recombinant, another ingredient on your label might. Find your product and we’ll check every ingredient on its label:

How much people look this up

Where 1,3-dmaa and Liraglutide Recombinant Sit Against Everything Else

Out of every supplement and medication people look up on HelloPharmacist, here is where these two land this week — and which way each has been moving.

Supplement 1,3-dmaa
Top half

#414 of 1,452 supplements looked up here in the last 7 days

29 days ago today
Medication Liraglutide Recombinant
Top 25%

#406 of 2,830 medications looked up here in the last 7 days

29 days ago today

Position among everything looked up on this site, not a measure of how commonly either one is used or how important it is. A supplement can climb this list because of a news story. It counts every request to the page, automated ones included, and nothing here identifies anyone.

Where does our data come from?
  • Source: the Natural Medicines (TRC Healthcare) clinical database — the evidence-graded professional reference for herb & supplement interactions.
  • Citation library: 103,510 references behind our interaction content, 65,311 of them resolved to verified PubMed/DOI sources. See every 1,3-dmaa reference on this page ↓
  • Freshness: we automatically re-check this combination every week — this pair was last verified September 13, 2026. The 1,3-dmaa and Liraglutide Recombinant records this page draws on were last updated July 10, 2026.
  • What “no known interaction” means: no documented interaction in the sources above — not a guarantee of safety. Supplements are studied far less than prescription drugs, so we say exactly what the evidence supports, and nothing more.
Data structure & sourcing designed and verified by .
Supplement

About 1,3-dmaa

What is 1,3-dmaa?

1,3-dmaa
  • Energy and stimulation
  • Pre-workout performance
  • Weight loss
  • Appetite suppression
  • Focus and concentration

DMAA (1,3-dimethylamylamine) is a synthetic stimulant that was sold in pre-workout and weight-loss supplements but has been linked to serious harm, including high blood pressure, heart problems, strokes, and deaths. The U.S. FDA and regulators in many countries have declared it illegal and unsafe in dietary supplements, so it should be avoided.

Synthetic compound (not a true plant part); sometimes claimed to come from geranium · Capsules, tablets, pre-workout powders (often as a hidden ingredient)

An interaction check asks whether these two react with each other — it does not ask whether 1,3-dmaa is a good idea for someone in your situation. Here is what our 1,3-dmaa record says about it on its own.

1,3-dmaa: dosing

There is no safe or established dose of DMAA. It is not approved as a dietary supplement ingredient, and we do not recommend taking it in any amount.Because DMAA may be hidden in some products, the safest approach is to avoid pre-workout or weight-loss supplements that list ingredients like dimethylamylamine, methylhexanamine, or Geranamine.

From our 1,3-dmaa monograph — the full record covers uses, side effects and every documented interaction.

Read the full 1,3-dmaa monograph & all interactions
Medication

About Liraglutide Injection

What Is Liraglutide Injection Used For?

Brand name: Saxenda

Saxenda is used alongside a reduced-calorie diet and increased physical activity for chronic weight management. It is approved for adults with a BMI of 30 or higher, or a BMI of 27 or higher if they also have at least one weight-related condition such as high blood pressure, type 2 diabetes, or dyslipidemia (abnormal cholesterol or fat levels). It is also approved for adolescents aged 12 and older who weigh more than 60 kg and meet certain BMI thresholds for obesity.

Saxenda should not be used together with other liraglutide-containing products or any other GLP-1 receptor agonist. Its safety and effectiveness in combination with other prescription or over-the-counter weight-loss products have not been established.

See full Liraglutide Injection drug information
Keep checking

Other Drugs & 1,3-dmaa

Browse every other medication we’ve checked against 1,3-dmaa — both the ones with a known interaction and the ones without. Select any drug for the full detail.

0Major
321Moderate
0Minor
2,508No known interaction
321 Moderate 2,508 No interaction
Moderate

321 interactions

Showing 60 of 321 moderate interactions — see all 321 on the 1,3-dmaa page.

No interaction 2,508 drugs checked — show the list

We also checked 1,3-dmaa against these medications and found no known interaction in our sources. Open any page to confirm.

Showing the 60 most looked-up of 2,508 medications checked with no known interaction — see the full 1,3-dmaa list.

See the full 1,3-dmaa interactions page
See every supplement checked against Liraglutide Recombinant, ranked by severity
Evidence & sources

1,3-dmaa References

The 21 references that drive our 1,3-dmaa monograph and interaction data, from the evidence-graded Natural Medicines (TRC Healthcare) database. Citations with a link open the study on PubMed or the publisher’s site.

  1. Adverse Event Report. Jack3d. Natural MedWatch, May 28, 2011.
  2. Gee P, Jackson S, Easton J. Another bitter pill: a case of toxicity from DMAA party pills. N Z Med J 2010;123:124-7.
  3. Removal of the dietary supplement DMAA. Army Medicine, Office of the Surgeon General, 2011. Available at: http://humanperformanceresourcecenter.org/dietary-supplements/files/dmaa-pdf. (Accessed 4 January 2012).
  4. McCarthy C, Farney TM, Canale RE, et al. A finished dietary supplement stimulates lipolysis and metabolic rate in young men and women. Nutr Metab Insights 2012;5:23-31. PubMed
  5. McCarthy C, Canale RE, Alleman RJ, et al. Biochemical and anthropometric effects of a weight loss dietary supplement in health men and women. Nutr Metab Insights 2012;5:13-22.
  6. Farney TM, McCarthy C, Canale RE, et al. Hemodynamic and hematologic profile of health adults ingesting dietary supplements containing 1,3-dimethylamylamine and caffeine. Nutr Metab Insights 2012;5:1-12.
  7. Young C, Oladipo O, Frasier S, et al. Hemorrhagic stroke in young healthy male following use of sports supplement Jack3d. Mil Med 2012;177(12):1450-4. PubMed
  8. Smith TB, Staub BA, Natarajan GM, et al. Acute myocardial infarction associated with dietary supplements containing 1,3-dimethylamylamine and Citrus aurantium. Tex Heart Inst J 2014;41(1):70-2. PubMed
  9. Liu Y, Santillo MF. Cytochrome P450 2D6 and 3A4 enzyme inhibition by amine stimulants in dietary supplements. Drug Test Anal. 2016;8(3-4):307-10. PubMed
  10. Archer JR, Dargan PI, Lostia AM, van der Walt J, Henderson K, Drake N, Sharma S, Wood DM, Walker CJ, Kicman AT. Running an unknown risk: a marathon death associated with the use of 1,3-dimethylamylamine (DMAA). Drug Test Anal. 2015 May;7(5):433-8. PubMed
  11. Armstrong M. Atrial Fibrillation with Rapid Ventricular Response following use of Dietary Supplement Containing 1,3 Dimethylamylamine and Caffeine. J Spec Oper Med. 2012 Winter;12(4):1-4. PubMed
  12. Bloomer RJ, Farney TM, Harvey IC, Alleman RJ. Safety profile of caffeine and 1,3-dimethylamylamine supplementation in healthy men. Hum Exp Toxicol. 2013 Nov;32(11):1126-36. PubMed
  13. Brown JA, Buckley NA. Toxicity from bodybuilding supplements and recreational use of products containing 1,3-dimethylamylamine. Med J Aust. 2013 May 6;198(8):414-5. PubMed
  14. Dolan SB, Gatch MB. Abuse liability of the dietary supplement dimethylamylamine. Drug Alcohol Depend. 2015 Jan 1;146:97-102. PubMed
  15. Dunn M. Have prohibition policies made the wrong decision? A critical review of studies investigating the effects of DMAA. Int J Drug Policy. 2017 Feb;40:26-34. PubMed

Medication overviews come from MedlinePlus (NIH); supplement label data from the NIH Dietary Supplement Label Database. Content is written and reviewed by licensed HelloPharmacist pharmacists — see our data sources and editorial standards.

Pharmacist Counseling Corner

Taking 1,3-dmaa and Liraglutide Recombinant Together: Common Questions

Is it safe to take 1,3-dmaa with Liraglutide Recombinant?
We do not list a known interaction between 1,3-dmaa and Liraglutide Recombinant. That does not guarantee the combination is risk-free, so confirm with your pharmacist or doctor — especially if you take other medications or have a health condition.
Do 1,3-dmaa and Liraglutide Recombinant have any of the same side effects?
Yes — our sources link each of them separately to 10 of the same effects. That is not an interaction: neither changes how your body handles the other. It does mean that if one of those effects turns up, it can be harder to tell which one is behind it. They are listed on this page with the source behind each.
Are 1,3-dmaa and Liraglutide Recombinant used for the same thing?
They overlap in purpose, which usually means the real question is whether you need both rather than whether they are safe together. This page lists the shared uses and how strong the evidence is for 1,3-dmaa in each. That is a conversation for your prescriber, especially if Liraglutide Recombinant is being adjusted to a target.
How was the 1,3-dmaa and Liraglutide Recombinant combination checked?
Interactions in our licensed database are recorded against drug classes. Liraglutide Recombinant is filed under 1 classification, and 1,3-dmaa has documented interactions with 2 drug classes — none of Liraglutide Recombinant's classifications are among them. A medication can belong to classes beyond those recorded in our dataset, so this describes how the check was run rather than guaranteeing safety.
Does 1,3-dmaa interact with any other medications?
Yes. 1,3-dmaa has 321 documented drug interactions in our database — Liraglutide Recombinant is simply not one of them. If you take anything else, it is worth checking each one; they are all listed on this page.
Does Liraglutide Recombinant interact with any supplements?
Yes. Liraglutide Recombinant has documented interactions with 239 supplements in our database — 1,3-dmaa is not one of them. The Liraglutide Recombinant interaction page linked on this page lists every one, ranked by severity.

Written and reviewed by the HelloPharmacist editorial staff. Our editorial policy

Where next

Keep Exploring

1,3-dmaa monograph Uses, safety profile, and every drug interaction in one place Liraglutide Injection drug information The full plain-English guide to this medication Liraglutide Recombinant supplement interactions Every supplement checked against Liraglutide Recombinant, ranked by severity Supplement interaction checker Check any supplement or product against your medications Browse medications A–Z Every drug we’ve checked against herbs & supplements References The 21 citations behind this page Ask a pharmacist Free, personal answer from our licensed team

Still Have a Question About Liraglutide Recombinant and 1,3-dmaa?

Our pharmacists answer your medication & supplement questions — free.

Ask a pharmacist

This information is for education only and is not a substitute for professional medical advice. Always check with your pharmacist or doctor before starting, stopping, or combining supplements and medications.